1. Home
  2. VTMX vs OGN Comparison

VTMX vs OGN Comparison

Compare VTMX & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTMX
  • OGN
  • Stock Information
  • Founded
  • VTMX 1998
  • OGN 1923
  • Country
  • VTMX Mexico
  • OGN United States
  • Employees
  • VTMX N/A
  • OGN N/A
  • Industry
  • VTMX
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTMX
  • OGN Health Care
  • Exchange
  • VTMX Nasdaq
  • OGN Nasdaq
  • Market Cap
  • VTMX 2.3B
  • OGN 2.5B
  • IPO Year
  • VTMX 2023
  • OGN N/A
  • Fundamental
  • Price
  • VTMX $28.55
  • OGN $9.16
  • Analyst Decision
  • VTMX Sell
  • OGN Hold
  • Analyst Count
  • VTMX 2
  • OGN 4
  • Target Price
  • VTMX $29.50
  • OGN $18.00
  • AVG Volume (30 Days)
  • VTMX 155.8K
  • OGN 4.5M
  • Earning Date
  • VTMX 07-24-2025
  • OGN 08-05-2025
  • Dividend Yield
  • VTMX 2.30%
  • OGN 0.92%
  • EPS Growth
  • VTMX N/A
  • OGN N/A
  • EPS
  • VTMX 0.04
  • OGN 2.69
  • Revenue
  • VTMX $263,061,301.00
  • OGN $6,281,000,000.00
  • Revenue This Year
  • VTMX $15.37
  • OGN N/A
  • Revenue Next Year
  • VTMX $11.02
  • OGN $1.02
  • P/E Ratio
  • VTMX $71.83
  • OGN $3.39
  • Revenue Growth
  • VTMX 11.49
  • OGN N/A
  • 52 Week Low
  • VTMX $21.30
  • OGN $8.01
  • 52 Week High
  • VTMX $30.73
  • OGN $23.10
  • Technical
  • Relative Strength Index (RSI)
  • VTMX 66.37
  • OGN 42.35
  • Support Level
  • VTMX $25.28
  • OGN $8.32
  • Resistance Level
  • VTMX $28.78
  • OGN $9.20
  • Average True Range (ATR)
  • VTMX 0.67
  • OGN 0.45
  • MACD
  • VTMX 0.24
  • OGN -0.11
  • Stochastic Oscillator
  • VTMX 92.14
  • OGN 39.04

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: